Cancer Immunotherapy and Immune Engineering focus on designing advanced immune-based strategies to recognize, target, and eliminate cancer cells. This rapidly evolving field integrates immunology, genetic engineering, and biotechnology to develop next-generation cancer therapies that enhance the body’s natural defense mechanisms against tumors.
This field includes immune cell engineering, therapeutic antibody development, and immune modulation strategies aimed at improving cancer treatment outcomes. Researchers collaborate across oncology, immunology, and molecular biology to advance personalized immunotherapies.
Several specialized areas are studied within Cancer Immunotherapy and Immune Engineering, including:
• Immune Cell Engineering
• Cancer Vaccines
• Adoptive Cell Therapy
• Immune System Modulation
• Tumor Immune Interaction
• Monoclonal Antibody Therapy
• Combination Immunotherapy
• Immune Memory Enhancement